Anderson AJM, et al. - The cost-effectiveness of annual melanoma screening in inflammatory bowel disease (IBD) was estimated. Researchers defined melanoma screening as receiving annual total body skin examinations starting at age 40 from a skin doctor. To estimate intervention costs and effectiveness, a Markov model was used. The authors discovered that screening for melanoma in IBD patients was effective but expensive. The most cost-effective strategy was screening every other year. The findings suggested that studies to identify IBD patients at the highest risk of developing melanoma could assist in targeting a prevention program in the most cost-effective manner.